Skip to content

Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm

Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005809
Acronym
SLEGD
Enrollment
268
Registered
2013-12-09
Start date
2013-03-31
Completion date
2015-03-31
Last updated
2013-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Neoplasms

Keywords

Endoscopic submucosal dissection, gastric neoplasm, second look endoscopy

Brief summary

Gastroenterologists often follow up second look endoscopy after endoscopic submucosal dissection(ESD) of gastric neoplasms because they want to prevent bleeding of procedure sites. But Goto suggested in his retrospective analysis that a second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary. So, the investigators try to identify the hypothesis prospectively in this study.

Interventions

PROCEDUREsecond look endoscopy

Second look endoscopy includes observation or prophylactic bleeding control of ESD site.

Sponsors

Inje University
CollaboratorOTHER
Kosin University Gospel Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* histological confirmed patients(gastric adenoma or adenocarcinoma) * performed gastric ESD patients about 24 hours before

Exclusion criteria

* perforation after ESD * piecemeal resection of ESD specimen * hemostatic agent or proton pump inhibitor users before ESD * heparin or antiplatelet agent users * Serious concurrent infection or nonmalignant illness that is uncontrolled * Psychiatric disorder that would preclude compliance * Allergy history to proton pump inhibitor

Design outcomes

Primary

MeasureTime frame
Post-ESD bleeding rate according to second look endoscopyUp to 60days

Secondary

MeasureTime frameDescription
bleeding complication rate according to location of lesion in stomach.Up to 60daysFundus, cardia, upper body, mid body, lower body, antrum anterior wall, posterior wall, great curvature, lesser curvature
Bleeding rate according to size of resected specimenUp to 60dayslongest diameter of specimen: millimeter
Post ESD bleeding rate according to total procedure time of endoscopic submucosal dissectionUp to 60days
Post ESD bleeding rate according to bleeding degree during endoscopic submucosal dissectionUp to 60daysMild: bleeding control time: \<1/3 of total ESD procedure time. Moderate: bleeding control time: 1/3\ 1/2 of total ESD procedure time Severe: bleeding control time: \>1/2 of total ESD procedure time

Countries

South Korea

Contacts

Primary ContactMoo In Park, MD
myjuyoung@hanmail.net82519905061

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026